Skip to Content

Innovator IBD® Breakout Opps ETF BOUT ETF Analysis

| Medalist Rating as of | See Innovator Investment Hub

Morningstar’s Analysis BOUT

Will BOUT outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Innovator IBD ® Breakout Opps ETF’s management team is rated Average, but a solid investment process still helps this strategy retain its Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor